EN
HI
Anthem Biosciences Chart
Anthem Biosciences Share Key Metrics
Volume
2.29 L
Market Cap
43647.62 CR
LTQ@LTP
1@772.00
ATP
773.6
Var Margin
13.52 %
Circuit Range
620-930
Delivery %
71.25 %
Value
17.73 CR
ASM/GSM
No
Market Lot
1
Summary
Anthem Biosciences share price is ₹772 as of 30 Jun, 2026. The stock Anthem Biosciences intraday movement has stayed between ₹764.20 and ₹777.00, while on a 52-week basis,Anthem Biosciences price 52 week high is ₹873.50 & its 52 week low is ₹579.15.
In terms of trading activity, Anthem Biosciences has recorded a volume of 229170 shares, The Anthem Biosciences has a market cap of ₹563195101 CR. The stock’s Average Traded Price (ATP) stands at ₹773.60, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹772.00.
Anthem Biosciences operates within a circuit range of ₹620.00 – ₹930.00, with a Value of ₹17.73 CR. The Delivery Percentage for the day is 71.25%. Additionally, Anthem Biosciences currently falls under the No framework, and trades with a market lot size of 1.
Anthem Biosciences Fundamentals
P/E Ratio
72.46
P/B Ratio
14.09
Div. Yield
0.26
Sector P/E
69.63
Sector P/B
3.12
Sec. Div. Yield
0.53
Anthem Biosciences Resistance and Support
Pivot 770.33
Resistance
First Resistance
780.66
Second Resistance
786.33
Third Resistance
796.66
Support
First Support
764.66
Second Support
754.33
Third Support
748.66
Anthem Biosciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-19 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-08 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
Anthem Biosciences News
Anthem Biosciences Ltd - 544449 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Anthem Biosciences Promoter Group member Aruna Ganesh sold her complete shareholding of 1.71 crore equity shares, representing 3.05% of the company's paid-up capital, through open market transactions on June 18, 2026.
Jun 19 2026 15:10:02
Anthem Biosciences Management
| Name | Position |
|---|---|
| Ajay Bhardwaj | Chairman & Managing Director, Chief Executive Officer |
| Ganesh Sambasivam | Whole Time Director |
Anthem Biosciences Similar Stocks
Biocon Ltd.
411.80
-3.45 (0.83%)
Alkem Laboratories Ltd.
5469.00
52.50 (0.97%)
Glenmark Pharmaceuticals Ltd.
2198.80
12.20 (0.56%)
Abbott India Ltd.
25270.00
-25.00 (0.10%)
Ipca Laboratories Ltd.
1641.70
-5.50 (0.33%)
Narayana Hrudayalaya Ltd.
1947.80
44.90 (2.36%)
Glaxosmithkline Pharmaceuticals Ltd.
2366.20
11.80 (0.50%)
Aster DM Healthcare Ltd.
772.90
7.20 (0.94%)
Anthem Biosciences FAQs
The Buying Price of Anthem Biosciences share is 772 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Anthem Biosciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Anthem Biosciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Anthem Biosciences shares is 72.46. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Anthem Biosciences shares is 14.09. Useful to assess the stock's value relative to its book value.
To assess Anthem Biosciences’s valuation compare Sector P/E, P/B which are 69.63 & 3.12 with sector averages, along with growth rates and financial metrics.
The Market Cap of Anthem Biosciences is 43647.62 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Anthem Biosciences share price is 873.50 & 579.15. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Anthem Biosciences belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
